Document:

EX-10.13

 Exhibit 10.13 

AVALANCHE BIOTECHNOLOGIES, INC. 

CHANGE IN CONTROL BENEFIT PLAN 

Section 1. INTRODUCTION. 

This Avalanche Biotechnologies, Inc. Change in Control Benefit Plan (the “Plan”) is established by Avalanche
Biotechnologies, Inc. (the “Company”) effective as of November 15, 2012. The purpose of the Plan is to provide for the acceleration of vesting of then-unvested shares subject to the compensatory equity awards held by
certain executive employees and members of the Company’s Board of Directors (the “Board”) upon the termination of their employment or service under specified circumstances following a Change in Control of the Company.
This Plan supersedes any equity vesting acceleration plan, policy or practice previously maintained by the Company in respect of its executive employees or board members for equity awards issued pursuant to the Company’s 2006 Equity Incentive
Plan (the “Equity Plan”). This Plan document also is the summary plan description for the Plan. 
 Section 2.
ELIGIBILITY FOR BENEFITS. 
 (a) General Rules. Subject to the requirements
set forth herein, the Company will grant certain benefits under the Plan to Eligible Participants. 
 (1) Definition of
“Eligible Participant.” For purposes of this Plan, Eligible Participants are those executive employees of the Company and members of the Board who are personally approved for participation in the Plan by the Board. The Board, in its
sole discretion, will determine whether an employee or Board member is an Eligible Participant and such determination will be binding and conclusive on all persons. 

(2) Release of Claims. To be eligible to receive the Vesting Acceleration (defined below) benefit under the Plan, an Eligible
Participant must execute a general waiver and release in substantially the form attached hereto as Exhibit A, Exhibit B or Exhibit C, as appropriate (a “Release”), and such Release must become effective in accordance with its
terms and allow it to become effective within 60 days following his or her “separation from service (as defined under Treasury Regulation Section 1.409A-1(h), a “Separation from Service”). The Company, in its
discretion, may modify the attached forms of release as reasonably necessary or appropriate to comply with applicable law, and may also incorporate the terms of the applicable release into a termination agreement or other agreement with the Eligible
Participant. 
 (3) Continuing Obligations. To be eligible to receive the Vesting Acceleration (defined below) benefit under the
Plan, an Eligible Participant must also continue to comply with his or her obligations under the confidential information and inventions assignment agreement entered into by the Eligible Participant with the Company (or, if applicable, any

  
 1. 

 
predecessor entity). In addition, to be eligible to receive benefits under the Plan, the Eligible Participant must resign from all positions he or she holds with the Company and any of its
affiliates, including, if the Eligible Participant is a member of the Board (or the board of directors of any affiliate), resignation from such body, to be effective no later than the date of Separation from Service (or such other date as requested
by the Board). 
 (b) Exceptions to Vesting Acceleration Benefit Entitlement. An employee or Board member, including an employee and
Board member who otherwise is an Eligible Participant, will not receive the Vesting Acceleration (defined below) benefit under the Plan if the employee or Board member is terminated for Cause (defined below) or commits Cause for termination
following notice of a Qualifying Termination (defined below) but prior to the actual date of Separation from Service, has his or her employment or service terminated because of his or her death or disability or the employee or Board member resigns
without Good Reason (defined below), as determined by the Company in its sole discretion. 
 Section 3. AMOUNT OF
BENEFIT. 
 (a) Termination without Cause or Resignation for Good Reason Following a Change in Control. If the
Company terminates an Eligible Participant’s employment or service without Cause (and other than as a result of death or disability), or if the Eligible Participant resigns his or her employment or service for Good Reason (defined below), in
either case at any time during the period commencing on the effective date of a Change in Control (defined below) and ending twelve (12) months following the effective date of the Change in Control, and provided such termination is also a
Separation from Service (such a termination, a “Qualifying Termination”), then subject to the Eligible Participant’s satisfaction of the requirements of this Plan, 100% of the then-unvested shares subject to the Eligible
Participant’s compensatory equity awards issued under the Equity Plan that are outstanding and unvested as of immediately prior to the Qualifying Termination (the “Stock Awards”) will vest, and, as applicable, become
exercisable as of immediately prior to the date of the Qualifying Termination (the “Vesting Acceleration”). The foregoing right to the Vesting Acceleration benefit will not modify the term of, or the post-termination exercise
period applicable to, the Eligible Participant’s Stock Awards. 
 (b) Definitions. 

(1) Cause. For purposes of the Plan, Cause will be determined in the sole discretion of the Board and will mean misconduct, including:
(i) conviction of any felony or any crime involving moral turpitude or dishonesty; (ii) willful and material breach of the Eligible Participant’s duties that has not been cured within 30 days after written notice from the Board of
Directors; (iii) intentional and material damage to the Company’s property; or (iv) material breach of the Proprietary Information and Inventions Agreement executed by the Eligible Participant. 

  
 2. 

 (2) Change in Control. For purposes of the Plan, a Change in Control will have the meaning
set forth in the Equity Plan. 
 (3) Good Reason. For purposes of the Plan, Good Reason will mean any of the following actions taken
without Cause by the Company or a successor corporation or entity without the Eligible Participant’s consent: (i) substantial reduction of the Eligible Participant’s rate of compensation; (ii) material reduction in the Eligible
Participant’s duties, provided, however, that a change in job position (including a change in title) shall not be deemed a “material reduction” unless the Eligible Participant’s new duties are substantially reduced from the prior
duties; (iii) failure or refusal of a successor to the Company to assume the Company’s obligations under this Agreement in the event of a Change in Control; (iv) relocation of the Eligible Participant’s principal place of
employment or service to a place greater than 50 miles from the Eligible Participant’s then current principal place of employment or service; (v) the requirement to increase the amount of time per week that the Eligible Participant
provides services to the Company or (vi) the requirement that the Eligible Participant cease other employment or consulting engagements, unless such employment and/or consulting engagement results in a direct conflict with the Company’s
business. 
 (4) Separation from Service. For purposes of the Plan, a Separation from Service means a “separation from
service” within the meaning of Treasury Regulations Section 1.409A-1(h), without regard to any alternative definition thereunder. 

Section 4. RIGHT TO INTERPRET PLAN; AMENDMENT AND
TERMINATION. 
 (a) Exclusive Discretion. The Plan Administrator will have the exclusive discretion and authority
to establish rules, forms, and procedures for the administration of the Plan and to construe and interpret the Plan and to decide any and all questions of fact, interpretation, definition, computation or administration arising in connection with the
operation of the Plan, including, but not limited to, the eligibility to participate in the Plan and amount of the Vesting Acceleration benefit provided under the Plan. The rules, interpretations, computations and other actions of the Plan
Administrator will be binding and conclusive on all persons. 
 (b) Amendment or Termination. The Company reserves the right to amend
or terminate this Plan (including the Exhibits) or the benefit provided hereunder at any time prior to a Change in Control of the Company. Any action amending or terminating the Plan will be in writing and executed by the Chief Executive Officer or
Chief Financial Officer of the Company. 
 Section 5. NO IMPLIED EMPLOYMENT
CONTRACT. 
 The Plan will not be deemed (i) to give any employee or other person any right to be retained in the
employ or service of the Company or (ii) to interfere with the right of the Company or the Company’s stockholders, as applicable, to discharge any employee or other person at any time, with or without cause, which right is hereby reserved.

  
 3. 

 Section 6. EXECUTION. 

To record the adoption of the Plan as set forth herein, effective as of August     , 2012, Avalanche Biotechnologies, Inc.
has caused its duly authorized officer to execute the same this 15 day of November, 2012. 
  

			
	AVALANCHE BIOTECHNOLOGIES, INC.
		
	By:	 	   /s/ Thomas Chalberg

			
		
	Title:	 	   President & CEO

  
 4. 

 For Employees Age 40 or Older 

Individual Termination 

EXHIBIT A 

RELEASE AGREEMENT 
 I
understand and agree completely to the terms set forth in the Avalanche Biotechnologies, Inc. Change in Control Benefit Plan (the “Plan”). 

I understand that this Release, together with the Plan, constitutes the complete, final and exclusive embodiment of the entire agreement
between the Company and me with regard to the subject matter hereof. I am not relying on any promise or representation by the Company that is not expressly stated therein. I understand that because I am receiving benefits under the Plan, the terms
of the Plan supersede any individually negotiated employment agreement that I may have with the Company relating to equity vesting acceleration benefits, and that I am not entitled to any equity vesting acceleration benefits under any such
agreement; provided, however, that all other remaining provisions of that agreement will remain in effect. Certain capitalized terms used in this Release are defined in the Plan. 

I hereby confirm my obligations under the Company’s proprietary information and inventions agreement. 

Except as otherwise set forth in this Release, I hereby generally and completely release the Company and its parents, subsidiaries,
successors, predecessors and affiliates, and its and their partners, members, directors, officers, employees, stockholders, shareholders, agents, attorneys, predecessors, insurers, affiliates and assigns, from any and all claims, liabilities and
obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date I sign this Release. This general release includes, but is not limited to:
(a) all claims arising out of or in any way related to my employment with the Company or the termination of that employment; (b) all claims related to my compensation or benefits, including salary, bonuses, commissions, vacation pay,
expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (c) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and
fair dealing; (d) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e) all federal, state, and local statutory claims, including claims for discrimination,
harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990 (as amended), the federal Age Discrimination in Employment Act (as
amended) (“ADEA”), the federal Employee Retirement Income Security Act of 1974 (as amended), and the California Fair Employment and Housing Act (as amended). 

Notwithstanding the foregoing, I understand that the following rights or claims are not included in my Release: (a) any rights or claims
for indemnification I may have pursuant to any 

  
 1. 

 For Employees Age 40 or Older 

Individual Termination 
  

 
written indemnification agreement with the Company or its affiliate to which I am a party; the charter, bylaws, or operating agreements of the Company or its affiliate; or under applicable law;
or (b) any rights which cannot be waived as a matter of law. In addition, I understand that nothing in this Release prevents me from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission
or the Department of Labor, except that I hereby waive my right to any monetary benefits in connection with any such claim, charge or proceeding. I hereby represent and warrant that, other than the claims identified in this paragraph, I am not aware
of any claims I have or might have that are not included in the Release. 
 I acknowledge that I am knowingly and voluntarily waiving and
releasing any rights I may have under the ADEA, and that the consideration given under the Plan for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled. I further acknowledge
that I have been advised by this writing, as required by the ADEA, that: (a) my waiver and release do not apply to any rights or claims that may arise after the date I sign this Release; (b) I should consult with an attorney prior to
signing this Release (although I may choose voluntarily not do so); (c) I have twenty-one (21) days to consider this Release (although I may choose voluntarily to sign this Release earlier); (d) I have seven (7) days following
the date I sign this Release to revoke the Release by providing written notice to an officer of the Company; and (e) this Release will not be effective until the date upon which the revocation period has expired, which will be the eighth day
after I sign this Release. 
 I acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as
follows: “A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the
debtor.” I hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any claims hereunder. 

I acknowledge that to become effective, I must sign and return this Release to the Company so that it is received not later than twenty-one
(21) days following the date it is provided to me. 
  

			
	 EMPLOYEE

		
	Name:	 	  

		
	Date:	 	  

  
 2. 

 For Employees Age 40 or Older 

Group Termination 

EXHIBIT B 

RELEASE AGREEMENT 
 I
understand and agree completely to the terms set forth in the Avalanche Biotechnologies, Inc. Change in Control Benefit Plan (the “Plan”). 

I understand that this Release, together with the Plan, constitutes the complete, final and exclusive embodiment of the entire agreement
between the Company and me with regard to the subject matter hereof. I am not relying on any promise or representation by the Company that is not expressly stated therein. I understand that because I am receiving benefits under the Plan, the terms
of the Plan supersede any individually negotiated employment agreement that I may have with the Company relating to equity vesting acceleration benefits, and that I am not entitled to any equity vesting acceleration benefits under any such
agreement; provided, however, that all other remaining provisions of that agreement will remain in effect. Certain capitalized terms used in this Release are defined in the Plan. 

I hereby confirm my obligations under the Company’s proprietary information and inventions agreement. 

Except as otherwise set forth in this Release, I hereby generally and completely release the Company and its parents, subsidiaries,
successors, predecessors and affiliates, and its and their partners, members, directors, officers, employees, stockholders, shareholders, agents, attorneys, predecessors, insurers, affiliates and assigns, from any and all claims, liabilities and
obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date I sign this Release. This general release includes, but is not limited to:
(a) all claims arising out of or in any way related to my employment with the Company or the termination of that employment; (b) all claims related to my compensation or benefits, including salary, bonuses, commissions, vacation pay,
expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (c) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and
fair dealing; (d) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e) all federal, state, and local statutory claims, including claims for discrimination,
harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990 (as amended), the federal Age Discrimination in Employment Act (as
amended) (“ADEA”), the federal Employee Retirement Income Security Act of 1974 (as amended), and the California Fair Employment and Housing Act (as amended). 

Notwithstanding the foregoing, I understand that the following rights or claims are not included in my Release: (a) any rights or claims
for indemnification I may have pursuant to any written indemnification agreement with the Company or its affiliate to which I am a party; the charter, bylaws, or operating agreements of the Company or its affiliate; or under applicable law;

  
 1. 

 For Employees Age 40 or Older 

Group Termination 
  

 
or (b) any rights which cannot be waived as a matter of law. In addition, I understand that nothing in this Release prevents me from filing, cooperating with, or participating in any
proceeding before the Equal Employment Opportunity Commission or the Department of Labor, except that I hereby waive my right to any monetary benefits in connection with any such claim, charge or proceeding. I hereby represent and warrant that,
other than the claims identified in this paragraph, I am not aware of any claims I have or might have that are not included in the Release. 

I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have under the ADEA, and that the consideration given
under the Plan for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled. I further acknowledge that I have been advised by this writing, as required by the ADEA, that:
(a) my waiver and release do not apply to any rights or claims that may arise after the date I sign this Release; (b) I should consult with an attorney prior to signing this Release (although I may choose voluntarily not to do so);
(c) I have forty-five (45) days to consider this Release (although I may choose voluntarily to sign this Release earlier); (d) I have seven (7) days following the date I sign this Release to revoke the Release by providing
written notice to an office of the Company; (e) this Release will not be effective until the date upon which the revocation period has expired, which will be the eighth day after I sign this Release; and (f) I have received with this
Release a detailed list of the job titles and ages of all employees who were terminated in this group termination and the ages of all employees of the Company in the same job classification or organizational unit who were not terminated. 

I acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as follows: “A general
release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.” I hereby
expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any claims hereunder. 

I acknowledge that to become effective, I must sign and return this Release to the Company so that it is received not later than forty-five
(45) days following the date it is provided to me. 
  

			
	 EMPLOYEE

		
	Name:	 	  

		
	Date:	 	  

  
 2. 

 EXHIBIT C 

RELEASE AGREEMENT 
 I
understand and agree completely to the terms set forth in the Avalanche Biotechnologies, Inc. Change in Control Benefit Plan (the “Plan”). 

I understand that this Release, together with the Plan, constitutes the complete, final and exclusive embodiment of the entire agreement
between the Company and me with regard to the subject matter hereof. I am not relying on any promise or representation by the Company that is not expressly stated therein. I understand that because I am receiving benefits under the Plan, the terms
of the Plan supersede any individually negotiated employment agreement that I may have with the Company relating to equity vesting acceleration benefits, and that I am not entitled to any equity vesting acceleration benefits under any such
agreement; provided, however, that all other remaining provisions of that agreement will remain in effect. Certain capitalized terms used in this Release are defined in the Plan. 

I hereby confirm my obligations under the Company’s proprietary information and inventions agreement. 

Except as otherwise set forth in this Release, I hereby generally and completely release the Company and its parents, subsidiaries,
successors, predecessors and affiliates, and its and their partners, members, directors, officers, employees, stockholders, shareholders, agents, attorneys, predecessors, insurers, affiliates and assigns, from any and all claims, liabilities and
obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date I sign this Release. This general release includes, but is not limited to:
(a) all claims arising out of or in any way related to my employment with the Company or the termination of that employment; (b) all claims related to my compensation or benefits, including salary, bonuses, commissions, vacation pay,
expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (c) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and
fair dealing; (d) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e) all federal, state, and local statutory claims, including claims for discrimination,
harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990 (as amended), the federal Age Discrimination in Employment Act (as
amended), the federal Employee Retirement Income Security Act of 1974 (as amended), and the California Fair Employment and Housing Act (as amended). 

Notwithstanding the foregoing, I understand that the following rights or claims are not included in my Release: (a) any rights or claims
for indemnification I may have pursuant to any 

  
 1. 

 
written indemnification agreement with the Company or its affiliate to which I am a party; the charter, bylaws, or operating agreements of the Company or its affiliate; or under applicable law;
or (b) any rights which cannot be waived as a matter of law. In addition, I understand that nothing in this Release prevents me from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission
or the Department of Labor, except that I hereby waive my right to any monetary benefits in connection with any such claim, charge or proceeding. I hereby represent and warrant that, other than the claims identified in this paragraph, I am not aware
of any claims I have or might have that are not included in the Release. 
 I acknowledge that I have read and understand Section 1542
of the California Civil Code which reads as follows: “A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have
materially affected his settlement with the debtor.” I hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to my release of any claims hereunder.

 I acknowledge that to become effective, I must sign and return this Release to the Company so that it is received not later than fourteen
(14) days following the date it is provided to me. 
  

			
	 EMPLOYEE

		
	Name:	 	  

		
	Date:	 	  

  
 2.bicx_ex101.htm

EXHIBIT 10.1

 

SETTLEMENT AGREEMENT

 

This SETTLEMENT AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into this 3rd day of June, 2014, by and between BIOCORRX, INC. f/k/a FRESH START PRIVATE MANAGEMENT, INC. (hereinafter “BioCorRx”), on the one hand, and FRESH START PRIVATE FLORIDA, LLC (hereinafter “FSP-FL”) and TIMOTHY JON JACKOBOICE (hereinafter “Jackoboice”), on the other hand; BioCorRx, FSP-FL and Jackoboice may be collectively referred to herein as the “Parties”.

 

WHEREAS, a dispute arose between the Parties concerning a License Agreement and Consulting Agreement relative to the Fresh Start Private Program as set forth in the pleadings in the case styled as Fresh Start Private Florida, LLC v. BioCoRx, Inc. f/k/a Fresh Start Private Management, Inc., Collier County Case No. 13-CA-1850 (hereinafter the “Litigation”); and

 

WHEREAS, the Parties have resolved their differences and desire to reduce their settlement understanding to a writing so that it shall be binding upon them as well as their respective current and former owners, principals, elected officials, officers, employees, ex-employees, agents, attorneys, representatives, insurers, spouses, successors, assigns, heirs, grantees and affiliates:

 

NOW, THEREFORE, in consideration of the foregoing premises and the following mutual promises (the receipt and sufficiency of such consideration being acknowledged by all Parties), the Parties agree as follows:

 

1. Recitals. The foregoing recitals are true and correct and are incorporated by reference.

 

2. Denial of Liability. No party is admitting wrongdoing, fault, or liability of any nature by entering into this Agreement.

 

3. Authority to Enter Into Agreement. Jackoboice represents that he has the authority to enter into this Agreement on behalf of FSP-FL, and to bind FSP-FL to the terms set forth in this Agreement. Kent Emry and Neil Muller represent that they have the authority to enter into this Agreement on behalf of BioCoRx, and to bind BioCoRx to the terms set forth in this Agreement.

 

4. *

 

5. *

 

6. Dismissal of Pending Litigation. Plaintiff, Defendant and Jackoboice shall sign the Stipulation attached hereto as Exhibit “3” and stipulate to the entry of the Order attached hereto as Exhibit “4”, which dismisses with prejudice all claims and counterclaims, and provides that the Court shall retain jurisdiction only for the purpose of enforcing this Settlement Agreement.*

___________________

* Information omitted pursuant to a Confidential Treatment Request filed with the Securities and Exchange Commission.

 

  

Page 1 of 4

  

 

7. Termination of Other Agreements. All prior and current agreements between the Parties are null and void as of the date of this Agreement. This includes, but is not limited to, the Florida License Agreement, and all Amendments thereto, the New York License Agreement, and the Consulting Agreement.

 

8. Non-Disparagement. The Parties agree that they will not engage in any conduct or communications designed or having the effect of disparaging the other party.

 

9. Release of All Claims by FSP-FL and Jackoboice Against BioCoRx. Except for any breach of this Agreement, FSP-FL and Jackoboice hereby release, acquit, satisfy, and forever discharge BioCorRx (including any and all employees, officers, directors, heirs, successors, assigns, legal representatives, attorneys and agents of BioCorRx) of and from any and all, and all manner of action and actions, cause and causes of action, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, agreements, promises, variances, trespasses, damages, judgments, executions, claims and demands whatsoever, in law or in equity, which FSP-FL or Jackoboice ever had, now have, or which any personal representative, successor, heir or assign of FSP-FL or Jackoboice, hereafter can, shall or may have involving or relating to the Litigation and/or the Fresh Start Private Program (as that term is defined in the Litigation) for, upon or by reason of any matter, cause or thing whatsoever, from the beginning of the world to the day of this Agreement.

 

10. Release of All Claims by BioCorRx Against FSP-FL and Jackoboice. Except for any breach of this Agreement, BioCorRx hereby releases, acquits, satisfies, and forever discharges FSP-FL and Jackoboice (including any and all employees, officers, directors, heirs, successors, assigns, legal representatives, attorneys and agents of FSP-Florida and Jackoboice) of and from any and all, and all manner of action and actions, cause and causes of action, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, controversies, agreements, promises, variances, trespasses, damages, judgments, executions, claims and demands whatsoever, in law or in equity, which BioCorRx ever had, now have, or which any personal representative, successor, heir or assign of BioCorRx, hereafter can, shall or may have involving or relating to the Litigation and/or the Fresh Start Private Program (as that term is defined in the Litigation) for, upon or by reason of any matter, cause or thing whatsoever, from the beginning of the world to the day of this Agreement.

 

11. Bear Own Attorneys’ Fees. The Parties shall bear their own attorneys’ fees and costs incurred relative to the Litigation.

 

12. Representation as to No Other Claims. The Parties to this Agreement expressly warrant and represent that they are not currently aware of any claims between them related to the Fresh Start Private Program (as that term is defined in the Litigation) or any other matter by and between themselves that have not been asserted in the Litigation other than those addressed in this Agreement.

 

13. Enforcement of the Settlement Agreement. This Agreement is subject to enforcement under Rule 1.700, et seq. of the Florida Rules of Civil Procedure, as the result of a court-ordered mediation conference. The Agreement is the collective product of the Parties, and shall not be construed against any Party as the drafter.

 

  

Page 2 of 4

  

 

14. Governing Law and Venue. This Agreement and all other documents executed in connection with this Agreement are governed by and shall be interpreted under Florida law. The sole and exclusive venue for any litigation among the Parties that may arise out of, or is related to this Agreement, or any documents executed in connection with this Agreement shall be in the Circuit Court in and for Collier County, Florida.

 

15. Enforceability. In the event that any provision of this Agreement is found to be void or unenforceable by a court of competent jurisdiction, the remaining provisions, in whole or in part, shall continue to be enforceable to the greatest extent allowed by law and to the same extent as if the void or unenforceable provision were omitted from the Agreement.

 

16. Entire Settlement Agreement. This Agreement contains the entire agreement between BioCorRx, FSP-FL and Jackoboice, and all prior or contemporaneous negotiations or representations are merged into this Agreement. This Agreement may not be amended or modified except in a written document signed by BioCorRx, FSP-FL and Jackoboice. The Parties represent that there were no oral statements outside of the terms of this Agreement that were material and that induced any Party to enter into this Agreement.

 

17. Paragraph Headings. Captions and paragraph headings in this Agreement are for convenience and reference only and do not define, describe, extend or limit the scope or intent of this Agreement or any provision herein.

 

18. Counterparts and Facsimile Signatures. This Agreement may be executed in counterparts with each copy being deemed an original. A facsimile signature on this Agreement will be deemed to be equivalent to an original signature.

 

19. Attorney’s Fees for Breach of Agreement. In the event any Party is required to take action to enforce the terms of this Agreement, including but not limited to bringing a lawsuit arising out of or relating to this Agreement, the prevailing party shall be entitled to recover its reasonable attorneys’ fees and costs through trial and any and all appeals. This provision also applies to any attorney’s fees and costs incurred in obtaining and enforcing the Final Judgment referenced in paragraph 5, above.

 

20. Website. FSP-FL and Jackoboice shall transfer to BioCorRx the domain and all rights to FSP-FL’s website, www.freshstartprivateflorida.com, within ten (10) days.

 

21. Confidentiality. The parties shall keep the financial terms of this settlement confidential, except they may discuss the terms with their lawyers, accountants, officers and directors. If BioCorRx’s securities lawyers advise them that other disclosures must be made, BioCorRx may do so.

 

  

Page 3 of 4

  

 

IN WITNESS WHEREOF, the parties hereto have set their hands on the date indicated herein.

 

Signed, sealed and delivered in the presence of:

 

	 	
FRESH START PRIVATE FLORIDA, LLC,

a Florida limited liability company 

	 
	 	 	 
	 	By:	
Glacier Holdings, LLC, as manager

	 
	 	 	 	 
	
Date: 6/3/14

	By:	
/s/ Timothy Jon Jackoboice

	 
	 	 	
Timothy Jon Jackoboice, as manager

	 
	 	 	 	 
	

Date: 6/3/14

	By:	
/s/ Timothy Jon Jackoboice

	 
	 	 	
Timothy Jon Jackoboice, individually

	 
	 	 	 	 
	 	 	 	 
	 	BIOCORX, INC., a Nevada Corporation	 
	 	 	 	 
	
Date: 6/3/14

	By:	
/s/ Kent Emry

	 
	
 

	 	
Kent Emry, as Chief Executive Officer

	 
	 	 	 	 
	

Date: 6/3/14

	By:	
/s/ Neil Muller

	 
	 	 	
Neil Muller, as President and Founder

	 
	 	 	 	 
	

Date: 6/3/14

	By:	
/s/ Edward K. Cheffy

	 
	 	 	
Edward K. Cheffy, Esq.

	 
	 	 	
Attorney for BioCorRx, Inc.

	 
	 	 	 	 
	
Date: 6/3/14

	By:	/s/ Casey K. Weidenmiller 	 
	 	 	
Casey K. Weidenmiller, Esq.

	 
	 	 	
Attorney for Fresh Start Private Florida, LLC and Timothy Jackoboice

	 
	 	 	 	 
	
Date: 6/3/14

	By:	/s/ Robin Doyle	 
	 	 	
Robin Doyle, Mediator

	 

 

 

Page 4 of 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]